Biolidics Ltd. Statistics
Want to see SG:8YY full AI Analyst Report?
Biolidics Ltd. (8YY) Stock Statistics & Valuation Metrics
Total Valuation
Biolidics Ltd. has a market cap or net worth of SGD 31.20M. The enterprise value is SGD 74.41M.
- Market Cap
- SGD 31.20M
- Enterprise Value
- SGD 74.41M
Share Statistics
Biolidics Ltd. has 1,733,441,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,733,441,800
- Owned by Insiders
- 9.17%
- Owned by Institutions
- ―
Financial Efficiency
Biolidics Ltd.’s return on equity (ROE) is -2.59 and return on invested capital (ROIC) is -75.44%.
- Return on Equity (ROE)
- -2.59
- Return on Assets (ROA)
- -0.78
- Return on Invested Capital (ROIC)
- -75.44%
- Return on Capital Employed (ROCE)
- -0.81
- Revenue Per Employee
- 328.69K
- Profits Per Employee
- -247.63K
- Employee Count
- 16
- Asset Turnover
- 1.04
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Biolidics Ltd. is -11.58. Biolidics Ltd.’s PEG ratio is 0.09.
- PE Ratio
- -11.58
- PS Ratio
- 5.59
- PB Ratio
- 20.79
- Price to FCF
- 97.53
- Price to Operating Cash Flow
- 97.04
- PEG Ratio
- 0.09
Income Statement
In the last 12 months, Biolidics Ltd. had revenue of 5.26M and earned -3.96M in profits. Earnings per share was -0.00.
- Revenue
- 5.26M
- Gross Profit
- 1.94M
- Operating Income
- -3.22M
- Pretax Income
- -3.99M
- Net Income
- -3.96M
- EBITDA
- -3.65M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was 393.00K and capital expenditures -2,000, giving a free cash flow of 391.00K billion.
- Operating Cash Flow
- 393.00K
- Free Cash Flow
- 391.00K
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Biolidics Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 1.03%
- Earnings Yield
- -8.00%
Stock Price Statistics
- Beta
- 0.66
- 52-Week Price Change
- -4.35%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.04
- Relative Strength Index (RSI)
- 35.07
- Average Volume (3m)
- 521.38K
Important Dates
Biolidics Ltd. upcoming earnings date is Feb 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Feb 26, 2027
- Ex-Dividend Date
- ―
Financial Position
Biolidics Ltd. as a current ratio of 1.17, with Debt / Equity ratio of 158.02%
- Current Ratio
- 1.17
- Quick Ratio
- 1.17
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- -0.51
- Interest Coverage Ratio
- -40.27
Taxes
In the past 12 months, Biolidics Ltd. has paid -29.00K in taxes.
- Income Tax
- -29.00K
- Effective Tax Rate
- 0.01
Enterprise Valuation
Biolidics Ltd. EV to EBITDA ratio is -15.34, with an EV/FCF ratio of 103.37.
- EV to Sales
- 5.93
- EV to EBITDA
- -15.34
- EV to Free Cash Flow
- 103.37
- EV to Operating Cash Flow
- 102.84
Balance Sheet
Biolidics Ltd. has SGD 494.00K in cash and marketable securities with SGD 2.77M in debt, giving a net cash position of -SGD 2.28M billion.
- Cash & Marketable Securities
- SGD 494.00K
- Total Debt
- SGD 2.77M
- Net Cash
- -SGD 2.28M
- Net Cash Per Share
- SGD 0.00
- Tangible Book Value Per Share
- SGD 0.00
Margins
Gross margin is 30.65%, with operating margin of -39.50%, and net profit margin of -44.73%.
- Gross Margin
- 30.65%
- Operating Margin
- -39.50%
- Pretax Margin
- -45.45%
- Net Profit Margin
- -44.73%
- EBITDA Margin
- -38.63%
- EBIT Margin
- -44.27%
Scores
- Smart Score
- ―
- AI Score
- 40
